AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Vascular ARDS Recruitment After Inhaled Nitric Oxide

RecruitingNAAges 18 Years - 80 YearsAllMassachusetts General Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Acute respiratory distress syndrome (ARDS) is when a person's lungs become inflamed, which can be caused by infection, trauma, surgery, blood transfusion, or burn. ARDS often leads to a situation where the person cannot breathe independently and needs machines' help. Once the lungs are inflamed, the small air sacs responsible for exchanging gases (i.e., ventilation) and the blood flow in the lungs (i.e., perfusion) can be affected. In the past, most research focused on studying ventilation physiology and how to help people breathe with machines. Less was done on perfusion because it requires imaging techniques such as computed tomography with intravenous contrast and radiation. One treatment option for low oxygen levels is inhaled nitric oxide (iNO), a gas that can dilate the lung blood vessels and improve oxygenation; however, it is not always clear whether this treatment will work. Pr

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adult intubated and mechanically ventilated patients (โ‰ฅ 18 years old) admitted to the intensive care unit (ICU) * ARDS diagnosis with mild to moderate severity by Berlin criteria1 (100 mmHg \< PaO2/FiO2 \<= 300 mmHg) * Presence of an arterial line for blood gas measurement and blood pressure monitoring and of a central line for hypertonic saline injection Exclusion criteria * Suspected pregnancy, pregnancy or less than six weeks postpartum * Younger than 18 years or older than 80 years * Patients with thorax perimeter not within the range of 37.5 - 134cm * Baseline methemoglobin โ‰ฅ 5% * Hemoglobin level less than 7 g/dl * Subjects enrolled in another interventional research study * Presence of pneumothorax * Usage of any devices with the electric current generation, such as a pacemaker or internal cardiac defibrillator * Past medical history of severe lung disease * Glucose-6-phosphate dehydrogenase (G6PD) deficiency * Cytochrome b5 reductase deficiency * Sickle cell disease * Patients that are receiving inhaled pulmonary vasodilators at the time of the enrollment * Hemodynamic instability is defined as: * Persistent systolic blood pressure \<90 mmHg and/or \>180 mmHg despite the use of vasopressor or vasodilators, or * Requiring an increment in inotropic vasopressors over the past two hours just before enrollment: more than 15 mcg/min for norepinephrine and dopamine, more than 10 mcg/min in epinephrine, and more than 50 mcg/ min for phenylephrine. * Increase in FiO2 \> 20%, increase in PEEP \> 5cmH2O over the past two hours just before enrollment * Hypernatremia (serum sodium \> 150 mEq/L) * Patients cannot be enrolled for DECT if they have: * History of allergic reaction to intravenous contrast * Renal dysfunction on the day of the study (serum creatinine \> 1.5 mg/dL) * Limited to sub-cohort 2: contraindications to prone positioning.
๐Ÿ’Š

What it tests

  • Nitric Oxide
๐Ÿ“

Where

1 site
Massachusetts General Hospital
Boston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy